Stay updated with breaking news from Patrick Lin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05.05.2022 - HANOVER, MD, May 05, 2022 (GLOBE NEWSWIRE) - Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need ...
The Arts Partnership previews two arts events happening soon in the community.
Zacks Investment Research upgraded shares of Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) from a sell rating to a hold rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who […]
Wall Street brokerages expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) to post earnings per share of ($0.18) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings of ($0.90) per share in the same quarter last year, which indicates a positive year-over-year […]
Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. According to Zacks, “Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality […]